U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07888426) titled 'Tolerability and Safety of Nano-Tocotrienols' on Oct. 04.
Brief Summary: The goal of this randomised controlled trial is to determine the long term safety and tolerability of nano-tocotrienols (50 - 400 mg/day for 6-months duration) to be used as a health supplement in both healthy individuals and those with Type 2 diabetes mellitus. The study will compare patients (both healthy and individuals with Type 2 diabetes mellitus) receiving placebo and those receiving nano-tocotrienols. They would then be followed up at 3 months and 6 months intervals to determine if there is any adverse events experienced with the supplement.
Study Star...